Generation of eicosanoids from 15(S)-hydroxyeicosatetraenoic acid in blood monocytes from steroid-dependent asthmatic patients

Biochemical Pharmacology

Volumn 56, Issue 4, 1998, Pages 535-541

  Chavis, Claude ^a   Vachier, Isabelle ^a   Bousquet, Jean ^a   Godard, Philippe ^a   Chanez, Pascal ^a  

^a INSERM   (France)

Author keywords

15(S) HETE; Asthma; Corticosteroids; Leukotriene B4; Lipoxins; Monocytes

Indexed keywords

15 HYDROPEROXYARACHIDONIC ACID; 5,15 DIHYDROXY 6,8,11,13 ICOSATETRAENOIC ACID; 8,15 DIHYDROXY 5,9,11,13 ICOSATETRAENOIC ACID; BECLOMETASONE; CALCIMYCIN; ICOSANOID; LEUKOTRIENE B4; PREDNISOLONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; ICOSANOID METABOLISM; IN VITRO STUDY; INHALATIONAL DRUG ADMINISTRATION; MONOCYTE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRAVIOLET SPECTROPHOTOMETRY;

ADRENAL CORTEX HORMONES; ADULT; AGED; ASTHMA; EICOSANOIDS; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LEUKOTRIENE B4; MIDDLE AGED; MONOCYTES;

EID: 0031720857     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00086-0     Document Type: Article

References (54)

1. Drazen J.M. Effects of leukotrienes on airway function. Crystal R.G., West J.B., Barnes P.J., Weibel E.R. The Lung (2nd edition). 1997;1287-1296 Lippincott-Raven, Philadelphia, New York.
2. Christie P.E., Spur B.W., Lee T.H. The effects of lipoxin A4 on airway responses in asthmatic subjects. Am Rev Respir Dis. 145:1992;1281-1284.
3. Serhan C.N. Lipoxins, biosynthesis and evidence for their involvement in respiratory disease. Robinson C. Lipid Mediators in Allergic Diseases of the Respiratory Tract. 1994;65-78 CRC Press, Boca Raton.
4. Westcott J.Y., Chang S., Balazy M., Stene D.O., Pradelles P., Maclouf J., Voelkel N.F., Murphy R.C. Analysis of 6-keto-PGF1 alpha, 5-HETE and LTC4 in rat lung: Comparison of GC-MS, RIA and EIA. Prostaglandins. 32:1986;857-873.
5. Lam S., Chan H., LeRiche J.C., Chan-Yeung M., Salari H. Release of leukotrienes in patients with bronchial asthma. J Allergy Clin Immunol. 81:1988;711-717.
6. Wenzel S.E., Larsen G.L., Johnston K., Voelkel N.F., Westcott J.Y. Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge. Am Rev Respir Dis. 142:1990;112-119.
7. Lee T.H., Crea A.E., Gant V., Spur B.W., Marron B.E., Nicolaou K.C., Reardon E., Brezinski M., Serhan C.N. Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis. 141:1990;1453-1458.
8. Lee T.H., Arm J. Leukotrienes. Allergy Proc. 12:1991;139-142.
9. Borgeat P. Biochemistry of the lipoxygenase pathways in neutrophils. Can J Physiol Pharmacol. 67:1989;936-942.
10. Serhan C.N., Hamberg M., Samuelsson B. Lipoxins, novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci USA. 83:1984;1983-1987.
11. Radeau T., Chavis C., Damon M., Michel F.B., Crastes-de-Paulet A., Godard P.H. Enhanced arachidonic acid metabolism and human neutrophil migration in asthma. Prostaglandins Leukot Essent Fatty Acids. 41:1990;131-138.
12. Sampson A.P., Thomas R.U., Costello J.F., Piper P.J. Enhanced leukotriene synthesis in leukocytes of atopic and asthmatic subjects. Br J Clin Pharmacol. 33:1992;423-430.
13. Chavis C., Godard P., Crastes-de-Paulet A., Damon M. Formation of lipoxins and leukotrienes by human alveolar macrophages incubated with 15(S)-HETE: a model for cellular cooperation between macrophages and airway epithelial cells. Eicosanoids. 5:1992;203-211.
14. Chavis C., Chanez P., Vachier I., Bousquet J., Michel F.B., Godard P. 5-15-diHETE and lipoxins generated by neutrophils from endogenous arachidonic acid as asthma biomarkers. Biochem Biophys Res Commun. 207:1995;273-279.
15. Maclouf J.A., Murphy R. Transcellular metabolism of neutrophil-derived leukotriene A4 by human platelets. J Biol Chem. 263:1988;174-181.
16. Serhan C.N. On the relationship between leukotriene and lipoxin production by human neutrophils: Evidence for differential metabolism of 15(S)-HETE and 5-HETE. Biochim Biophys Acta. 1004:1989;158-168.
17. Levy B.D., Romano M., Chapman H.A., Reilly J.J., Drazen J., Serhan C.N. Human alveolar macrophages have 15-lipoxygenase and generate 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid and lipoxins. J Clin Invest. 92:1993;1572-1579.
18. Chavis C., Vachier I., Chanez P., Bousquet J., Godard P. 5(S),15(S)-Dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: Dual specificity of 5-lipoxygenase toward endogenous and exogenous precursors. J Exp Med. 183:1996;1633-1643.
19. Pawlowski N.A., Kaplan G., Hamill A.L., Cohn Z.A., Scott W.A. Arachidonic acid metabolism by human monocytes. J Exp Med. 158:1983;393-412.
20. Pueringer R.J., Bahns C.G., Hunninghake G.W. Alveolar macrophages have greater amounts of the enzyme 5-lipoxygenase than do monocytes. J Appl Physiol. 73:1992;781-786.
21. Bousquet J., Chanez P., Lacoste J.Y., Barneon G.N., Ghavanian N., Enander I., Venge P., Ahlstedt S., Simony-Lafontaine J., Godard P., Michel F.B. Eosinophilic inflammation in asthma. N Engl J Med. 323:1990;1033-1039.
22. Roberts R.L., Gallin J.I. Rapid method for isolation of normal human peripheral blood eosinophils on discontinuous Percoll gradients and comparison with neutrophils. Blood. 65:1985;433-440.
23. Goldyne M.E., Burrish G.F., Poubelle P., Borgeat P. Arachidonic acid metabolism among human mononuclear leukocytes. J Biol Chem. 259:1984;8815-8819.
24. Bigby T.D., Holtzmann M.J. Enhanced 5-lipoxygenase activity in lung macrophages compared to monocyte from normal subjects. J Immunol. 138:1987;1546-1550.
25. Weide I., Tippler B., Syrovets T., Simmet T. Plasmin is a specific stimulus of the 5-lipoxygenase pathway of human peripheral monocytes. Thromb Haemost. 76:1996;561-568.
26. Nassar G.M., Montero A., Fukunaga M., Badr K.F. Contrasting effects of proinflammatory and T-helper lymphocyte subset-2 cytokines on the 5-lipoxygenase pathway in monocytes. Kidney Int. 51:1997;1520-1528.
27. Cashman J.R., Lambert C., Sigal E. Inhibition of human leukocyte 5-lipoxygenase by 15-HPETE and related eicosanoids. Biochem Biophys Res Commun. 155:1988;38-44.
28. Petrich K., Ludwig P., Kuhn H., Schewe T. The suppression of 5-lipoxygenation of arachidonic acid in human polymorphonuclear leukocytes by the 15-lipoxygenase product (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid: Structure-activity relationship and mechanism of action. Biochem J. 314:1996;911-916.
29. 4 as a mediator of early and late reactions to antigens in humans: The effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 83:1989;634-642.
30. Linden M. The effects of β-2 adrenoreceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes. Br J Pharmacol. 107:1992;156-160.
31. De Caterina R., Sicari R., Giannessi D., Paggiaro P.L., Paoletti P., Lazzerini G., Bernini W., Solito E., Parente L. Macrophage-specific eicosanoid synthesis inhibition and lipocortin-1 induction by glucocorticoids. J Appl Physiol. 75:1993;2368-2375.
32. Riddick C.A., Ring W.L., Baker J.R., Hodulik C.R., Bigby T.D. Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells. Eur J Biochem. 246:1997;112-118.
33. Sebaldt R.J., Sheller J.S., Oates J.R., Roberts L.J., Fitzgerald G.A. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci USA. 87:1990;6974-6978.
34. 4 biosynthesis ex vivo. Arthritis Rheum. 36:(Suppl.):1993;F269.
35. Thomas E., Leroux J.L., Blotman F., Descomps B., Chavis C. Enhancement of leukotriene A4 biosynthesis in neutrophils from patients with rheumatoid arthritis after a single glucocorticoid dose. Biochem Pharmacol. 49:1995;243-248.
36. Wenzel S.E., Trudeau J.B., Wescott J.Y., Beam W.R., Martin R.J. Single oral dose of prednisone decreases leukotriene B4 production by alveolar macrophages from patients with nocturnal asthma but not control subjects: Relationship to changes in cellular influx and FEV1. J Allergy Clin Immunol. 94:1994;870-881.
37. Madretsma G.S., Vandijk A.P.M., Tak C.J.A.M., Wilson J.H.P., Zijlstra F.J. Inhibition of the production of mediators of inflammation by corticosteroids is a glucocorticoid receptor-mediated process. Mediat Inflamm. 5:1996;100-103.
38. Vachier I., Chavis C., Godard P., Bousquet J., Chanez P. The effect of long term treatment with glucocorticoids on PMN and monocyte LTB4 production in asthmatic patients. Am J Respir Crit Care Med. 151:1995;A215.
39. Oosterhoff Y., Overbeek S.E., Douma R., Noordhoek J.A., Postma D.S., Hoogsteden H.C., Zijlstra F.J. Lower leukotriene C-4 levels in bronchoalveolar lavage fluid of asthmatic subjects after 2.5 years of inhaled corticosteroid therapy. Mediat Inflamm. 4:1995;426-430.
40. Vachier I., Kumlin M., Deviller P., Dahlen S.E., Bousquet J., Godard P., Chanez P. Urinary LTE4 and EDN in untreated and steroid-dependent asthmatic patients. Eur Respir J. 9:1996;418S.
41. Vand Dijk A.P.M., McCafferty D.M., Wilson J.H.P., Zijlstra F.J. 15-Hydroxyeicosatetraenoic acid has minor antiinflammatory properties in colitis. Agents Actions. 38:1993;120-121.
42. Kuhn H., Chan L. The role of 15-lipoxygenase in atherogenesis: Pro- and antiatherogenic actions. Curr Opin Lipidol. 8:(2):1997;111-117.
43. Vachier I., Roux S., Chanez P., Loubatière J., Térouanne B., Nicolas J., Godard P. Glucocorticoids induced down-regulation of glucocorticoid receptor mRNA GR expression in asthma. Clin Exp Immunol. 103:1996;311-315.
44. Kumlin M., Hamberg M., Granstrom E., Bjorck T., Dahlen B., Matsuda H., Zetterstrom O., Dahlen S.E. 15(S)-hydroxyeicosatetraenoic acid is the major arachidonic acid metabolite in human bronchi: association with airway epithelium. Arch Biochem Biophys. 282:1990;254-262.
45. Sigal E., Dicharry S., Highland E., Finkbeiner W.E. Cloning of human airway 15-lipoxygenase: identity to the reticulocyte enzyme and expression in the epithelium. Am J Physiol. 262:1992;L392-L398.
46. Shannon V.R., Chanez P., Bousquet J., Holtzman J. Histochemical evidence for induction of arachidonate 15-lipoxygenase in airway disease. Am Rev Respir Dis. 147:1993;1024-1028.
47. Campbell A.M., Chanez P., Vignola A.M., Bousquet J., Couret I., Michel F.B., Godard P. Functional characteristics of bronchial epithelium obtained by brushing from asthmatic and normal subjects. Am Rev Respir Dis. 147:1993;529-534.
48. Lassalle P., Delneste Y., Gosset P., Tonnel A.B. Endothelial cells and asthma. Tarayre J.P., Vargaftig B., Carilla E. New Concept in Asthma. 1993;200-208 Macmillan Press, London.
49. Ibe B.O., Falck J.R., Johnson A.R., Campbell W.B. Regulation of synthesis of prostacyclin and HETEs in human endothelial cells. Am J Physiol. 256:1989;C1168-C1175.
50. Lopez S., Vila L., Breviario F., de Castellarnau C. Interleukin-1 (IL-1) increases 15-hydroxyeicosatetraenoic acid formation in cultured human endothelial cells. Biochim Biophys Acta. 1170:1993;17-24.
51. Papayianni A., Serhan C.N., Brady H.R. Lipoxin A-4 and B-4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J Immunol. 156:1996;2264-2272.
52. Ferrante J.V., Huang Z.H., Nandoskar M., Hii C.S.T., Robinson B.S., Rathjen D.A., Poulos A., Morris C.P., Ferrante A. Altered responses of human macrophages to lipopolysaccharide by hydroperoxy eicosatetraenoic acid, hydroxy eicosatetraenoic acid, and arachidonic acid - Inhibition of tumor necrosis factor (TNF) production. J Clin Invest. 99:1997;1445-1452.
53. Serhan C.N., Drazen J.M. Antiinflammatory potential of lipoxygenase-derived eicosanoids: A molecular switch at 5 and 15 positions? J Clin Invest. 99:1997;1147-1148.
54. Lee T.H. Lipoxin A4, a novel anti-inflammatory molecule? Thorax. 50:1995;111-112.